Work

The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity

Year: 2026

Type: article

Source: Cancer Research

DOI: 10.1158/0008-5472.can-25-5580

Institutions: Innovent Biologics (China), Jinan University, Southern University of Science and Technology, ShenZhen People’s Hospital, Nanchang University

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Innovent Biologics

OpenAlex ID: W7204969338

FWCI:

Cites:

Cited by:

Related to: 10